Molecular Pharmacological research on the roles of lymphocytic cholinergic system in T cell function

淋巴细胞胆碱能系统对T细胞功能作用的分子药理学研究

基本信息

项目摘要

Human Leukemic T cell lines CCRF-CEM and MOLT-3 were used.1.Effects of small interfering RNA (siRNA) on Ca^<2+> signaling in T cells.Transfection of anti-M_3, anti-M_5 and anti-α7 small interfering RNA significantly down-regulated respective mRNA expression, while no changes were observed in gene expression of other mAChR subtypes or nAChR subunits. Ca^<2+> signals evoked by oxotremorine-M (Oxo-M), a non-selective mAChR agonist, were reduced by anti-M_3 or anti-M_5 siRNA. Ca^<2+> signals evoked by nicotine were reduced by anti-α7 siRNA. These findings indicate that M_3, M_5 mAChR and α7 nAChR subtypes play major roles in Ca^<2+> signals to acetylcholine in T cells, and suggest that these receptors are involved in regulation of immune function.2.Effects of anti-CD11a monoclonal antibody on lymphocytic cholinergic activity in T cells.Anti-CD11a mAb significantly increased both the ACh content of MOLT-3 cells and its release into the culture medium, whereas simvastatin had no effect on ACh content or its release. On the other hand, simvastatin completely blocked the enhancement of ACh content and release evoked by anti-CD11a mAb.Similarly, anti-CD11a mAb significantly up-regulated ChAT mRNA expression, whereas simvastatin had no effect on the expression of ChAT mRNA. But when added to the culture medium along with anti-CD11a mAb, simvastatin completely blocked anti-CD11a mAb-induced ChAT mRNA expression. Likewise, simvastatin significantly diminished anti-CD11a mAb-induced expression of M_5 mAChR mRNA. By contrast, neither simvastatin nor anti-CD11a mAb had any effect on expression of M_3 or M_4 mAChR mRNA.Consistent with its effects on ChAT expression and ACh content and release, anti-CD11a mAb significantly enhanced ChAT-catalyzed ACh synthesis in MOLT-3 cells, as compared to control. And consistent with all of the results summarized above, simvastatin alone did not affect basal ChAT activity, but did abolish the anti-CD11a mAb-induced enhancement of that activity.
1.小干扰RNA(siRNA)对人白血病T细胞系CCRF-CEM和MOLT-3细胞内Ca^<2+>信号转导的影响:抗M3、抗M5和抗α7小干扰RNA转染后,可显著下调相应mRNA的表达,而对其他mAChR亚型和nAChR亚基的基因表达无明显影响。抗M_3或抗M_5的siRNA可抑制非选择性mAChR激动剂氧化震颤素M(oxotremorine-M,Oxo-M)诱发的Ca^<2+>信号。尼古丁诱发的Ca^<2+>信号可被抗α7 siRNA抑制。这些结果表明,M_3、M_5和α7 nAChR亚型在T细胞乙酰胆碱的Ca^2+信号中起主要作用,抗CD 11 a单克隆抗体对T淋巴细胞胆碱能活性的影响:抗CD 11 a单克隆抗体能显著增加MOLT-1细胞内ACh含量,并能显著降低MOLT-1细胞内ACh含量,提示MOLT-1细胞内ACh含量与MOLT-1细胞内ACh含量呈负相关。3细胞及其释放到培养基中,而辛伐他汀没有影响ACh含量或其释放。辛伐他汀可完全阻断抗CD 11 a单抗引起的ACh含量和释放的增加,抗CD 11 a单抗可显著上调ChAT mRNA的表达,而辛伐他汀对ChAT mRNA的表达无影响。但当沿着抗CD 11 a mAb加入培养液中时,辛伐他汀完全阻断抗CD 11 a mAb诱导的ChAT mRNA表达。同样,辛伐他汀也能显著降低抗CD 11 a单抗诱导的M_5 mAChR mRNA的表达。与对照组相比,辛伐他汀和抗CD 11 a单抗对MOLT-3细胞M_3和M_4 mAChR mRNA的表达无影响,抗CD 11 a单抗对ChAT表达和ACh含量及释放的影响与对照组一致,显著增强了MOLT-3细胞ChAT催化的ACh合成。与以上总结的所有结果一致,单独使用辛伐他汀不影响基础ChAT活性,但确实消除了抗CD 11 a mAb诱导的该活性增强。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suppression of antibody production and nicotinic acetylcholine receptor α7 subunit gene expression in mononuclear leukocytes of chronically nicotine-treated mice.
长期尼古丁治疗小鼠的单核白细胞中抗体产生和烟碱乙酰胆碱受体α7亚基基因表达的抑制。
Expression of acetylcholine in lymphocytes and modulation of an independent lymphocytic cholinergic activity by immunological stimulation
  • DOI:
    10.1163/15693910260698320
  • 发表时间:
    2002-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Fujii;Yoshihiro Watanabe;K. Fujimoto;K. Kawashima
  • 通讯作者:
    T. Fujii;Yoshihiro Watanabe;K. Fujimoto;K. Kawashima
Suppression of antibody production and nicotinic acetylcholine receptor a7 subunit gene expression in mononuclear leukocytes of chronically nicotine-treated mice
长期尼古丁治疗小鼠单核白细胞中抗体产生和烟碱乙酰胆碱受体 a7 亚基基因表达的抑制
Simvastatin inhibits activation of an independent, non-neuronal cholinergic system in T lymphocytes via CDlla molecule
辛伐他汀通过 CDlla 分子抑制 T 淋巴细胞中独立的非神经元胆碱能系统的激活
Phorbol 12-myrustate 13-acetate increases choline acetyltransferase activity in human leukemic T celkl line MOLT-3
佛波醇 12-肉豆蔻酸 13-乙酸酯增加人白血病 T 细胞系 MOLT-3 中的胆碱乙酰转移酶活性
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJII Takeshi其他文献

FUJII Takeshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJII Takeshi', 18)}}的其他基金

Screening for new genes involved in antibiotics production from soil-metagenome using metatranscriptomic analysis
使用宏转录组分析从土壤宏基因组中筛选参与抗生素生产的新基因
  • 批准号:
    25660069
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study for gene expression control mechanism involved in the soil environment adaptation strategies of actinomycetes
放线菌土壤环境适应策略涉及的基因表达调控机制研究
  • 批准号:
    25292040
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Interaction between vacuolar H+ ATPase and lymphocytic cholinergic system in regulation of immune function
液泡H ATP酶与淋巴细胞胆碱能系统在免疫功能调节中的相互作用
  • 批准号:
    23590121
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A function of the dentate gyrus in the hippocampus based on the neurotrophic hypothesis of depression: a neuroimaging study
基于抑郁症神经营养假说的海马齿状回功能:一项神经影像学研究
  • 批准号:
    23791317
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Study on the control of gene expression network in Streptomyces growing in the soil environment
土壤环境中链霉菌基因表达网络调控研究
  • 批准号:
    21380050
  • 财政年份:
    2009
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of lymphocytic cholinergic system in regulation of fat metabolism
淋巴细胞胆碱能系统在脂肪代谢调节中的作用
  • 批准号:
    20590096
  • 财政年份:
    2008
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of acetylcholine receptor using muscarinic receptor knockout mice.
使用毒蕈碱受体敲除小鼠对乙酰胆碱受体进行功能分析。
  • 批准号:
    18390073
  • 财政年份:
    2006
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
On a statistical prediction for a variation of typhoon formation, intensification, and course with the sea surface temperature rise in the Northwest Pacific
西北太平洋台风形成、强度和路径随海面温度上升变化的统计预测
  • 批准号:
    07680496
  • 财政年份:
    1995
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Consequences of MALT1 mutation for B cell tolerance
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
RNA helicases; switched paralogue dependency as an exploitable vulnerability in aggressive B cell lymphoma.
RNA解旋酶;
  • 批准号:
    EP/Y030303/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Roles of immune cells derived from clonal hematopoiesis in B-cell lymphomas
克隆造血来源的免疫细胞在 B 细胞淋巴瘤中的作用
  • 批准号:
    24K19213
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
  • 批准号:
    MR/X03383X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Fellowship
Exploration of T- and B-cell receptors to eliminate the foreign body reaction from synthetic polymeric scaffolds
探索 T 细胞和 B 细胞受体以消除合成聚合物支架的异物反应
  • 批准号:
    24K19917
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
  • 批准号:
    478278
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
Artificial Intelligence analysis of the immune-checkpoint and immuno-oncology in B-cell non-Hodgkin lymphoma
B 细胞非霍奇金淋巴瘤免疫检查点和免疫肿瘤学的人工智能分析
  • 批准号:
    23K06454
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
Identification of pathogenesis-promoting interferon-stimulated genes and development of regulatory strategies in mature B-cell tumors
成熟 B 细胞肿瘤中干扰素刺激促进发病基因的鉴定和调控策略的开发
  • 批准号:
    23K15330
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了